Title:
A Randomized, Multi-center, Open-label, Active-controlled Phase 3 Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot (CAM2029) Versus Octreotide LAR or Lanreotide ATG in Patients With GEP-NET
Phase:
III
Contact:
Elisabeth Lawrence / Kontaktperson
Email-Address:
Elisabeth.Lawrence@med.uni-heidelberg.de
Clinical Investigator:
Dr. Leonidas Apostolidis
Registration:
Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe
NCT05050942
EudraCT-Number:
Siehe EU klinisches Studienregister
2021-000849-40